25mg Eltrombopag Tablets

25mg Eltrombopag Tablets Specification

Pacakaging (Quantity Per Box)
28 tablets

Packaging Type
Blister pack

Salt Composition
Eltrombopag Olamine 25 mg

Origin of Medicine
India

Indication
Treatment of low platelet count in patients with chronic ITP, aplastic anemia, and chronic hepatitis C

Life Span
24 months from date of manufacture

Dosage Form
Solid oral tablet

Brand Name
Eltromycin 25

Drug Type
Prescription Medicine, Allopathic

Ingredients
Eltrombopag Olamine

Physical Form
Tablets, Tablets

Function
Thrombopoietin receptor agonist, increases platelet production, Thrombopoietin receptor agonist to increase platelet production

Recommended For
Chronic immune (idiopathic) thrombocytopenia, aplastic anemia, chronic hepatitis C

Dosage
As directed by physician

Dosage Guidelines
Take orally once daily on an empty stomach or as prescribed

Suitable For
Adults and pediatric patients aged 1 year and above, Adults

Quantity
28 tablets per box

Storage Instructions
Store below 30C, protect from moisture and light

Administration Route
Oral

Precautions
Use caution in patients with liver impairment; monitor platelet counts regularly

Approval
Manufactured under WHO-GMP certified facility

Contraindications
Hypersensitivity to Eltrombopag or any excipients

Side Effects
May include nausea, diarrhea, headache, and increased liver enzymes

Color
Light brown

Prescription Required
Yes

Therapeutic Class
Hematopoietic agent

Shape
Round, film-coated tablet

25mg Eltrombopag Tablets Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash Against Delivery (CAD), Cash on Delivery (COD), Cash in Advance (CID)

Supply Ability
100 Boxes Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About 25mg Eltrombopag Tablets

Eltromycin 25 (Eltrombopag Olamine 25mg) tablets are a must-have hematopoietic agent, renowned for their gilt-edged quality and top-tier efficacy in raising platelet counts. Each light brown, round, film-coated tablet is manufactured in a WHO-GMP certified facility, marking them as superior in safety and reliability. This prescription-only, oral medication is triumphant for managing chronic immune thrombocytopenia, aplastic anemia, and hepatitis C-related low platelet counts. Packaged conveniently in blister packs of 28, Eltromycin 25 is recommended for adults and pediatric patients aged 1 year and above, ensuring broad therapeutic utility.

Material Feature, Type Of Usage, Application Media

Eltromycin 25 tablets deliver gilt-edged results with premium film-coated, round, light brown tablets, ensuring superior stability and ease of oral administration. Specially crafted for repetitive, once-daily intake, these solid tablets are used in a clinical setting or at home after prescription. Their primary application is through the oral route, where the medication acts as a thrombopoietin receptor agonist, effectively stimulating platelet production and providing triumphant outcomes for patients with chronic ITP, aplastic anemia, and chronic hepatitis C.

FOB Port, Packaging Details, and Delivery Time

Our sales price for Eltromycin 25 covers not only a superior medicinal product but also top-notch logistics and packing & dispatch services. Each box contains 28 tablets, safely sealed in blister packs to maintain efficacy with a 24-month shelf life. FOB Port is India, with prompt delivery and efficient handling ensuring minimum markdown on transit time. Packaging instructions emphasize protection from moisture and light, ensuring the product arrives ready for immediate clinical use.

FAQ's of 25mg Eltrombopag Tablets:

Q: How should Eltromycin 25 (Eltrombopag 25mg) tablets be taken for optimal results?

A: Eltromycin 25 tablets should be taken orally, once daily, on an empty stomach or as directed by your physician. Always follow dosage instructions precisely for best therapeutic effect.

Q: What is the primary benefit of using Eltromycin 25 for low platelet counts?

A: The primary benefit of Eltromycin 25 is its proven ability to increase platelet production in patients with chronic immune thrombocytopenia, aplastic anemia, or hepatitis C-related thrombocytopenia, thereby reducing bleeding risk.

Q: When is it advisable to start Eltromycin 25 therapy in patients?

A: Eltromycin 25 is recommended when a patient with chronic ITP, aplastic anemia, or chronic hepatitis C experiences persistent low platelet counts not adequately managed by other treatments. A physician's prescription is required.

Q: Where is Eltromycin 25 manufactured, and what quality standards does it follow?

A: Eltromycin 25 is manufactured in India under strict WHO-GMP certified conditions, ensuring international quality and safety standards are consistently met.

Q: What precautions should patients take while using Eltromycin 25 tablets?

A: Patients with liver impairment should use Eltromycin 25 cautiously, and regular monitoring of platelet counts is essential. Hypersensitivity to eltrombopag or excipients contraindicates use.

Q: How is Eltromycin 25 packaged and delivered to ensure product integrity?

A: Eltromycin 25 is supplied in blister packs containing 28 tablets per box. Packaging is designed for protection from moisture and light, and logistics are handled to ensure timely, intact delivery.